Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kiniksa Pharmaceuticals International (KNSA) Capital Expenditures: 2017-2024

Historic Capital Expenditures for Kiniksa Pharmaceuticals International (KNSA) over the last 8 years, with Dec 2024 value amounting to $277,000.

  • Kiniksa Pharmaceuticals International's Capital Expenditures rose 2495.65% to $597,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 million, marking a year-over-year increase of 293.39%. This contributed to the annual value of $277,000 for FY2024, which is 113.08% up from last year.
  • According to the latest figures from FY2024, Kiniksa Pharmaceuticals International's Capital Expenditures is $277,000, which was up 113.08% from $130,000 recorded in FY2023.
  • Kiniksa Pharmaceuticals International's 5-year Capital Expenditures high stood at $415,000 for FY2021, and its period low was $105,000 during FY2022.
  • Over the past 3 years, Kiniksa Pharmaceuticals International's median Capital Expenditures value was $130,000 (recorded in 2023), while the average stood at $170,667.
  • As far as peak fluctuations go, Kiniksa Pharmaceuticals International's Capital Expenditures plummeted by 91.16% in 2020, and later surged by 113.08% in 2024.
  • Kiniksa Pharmaceuticals International's Capital Expenditures (Yearly) stood at $283,000 in 2020, then spiked by 46.64% to $415,000 in 2021, then crashed by 74.70% to $105,000 in 2022, then climbed by 23.81% to $130,000 in 2023, then soared by 113.08% to $277,000 in 2024.